Polymorphisms in NAT1 Gene and Colorectal Cancer Risk
Author Information
Author(s): AL Hubbard, C Moyes, AH Wyllie, CAD Smith, DJ Harrison
Primary Institution: University of Edinburgh
Hypothesis
Are polymorphisms in the NAT1 gene associated with colorectal cancer risk?
Conclusion
Polymorphisms in the NAT1 gene are infrequent and do not appear to be independently associated with colorectal cancer risk.
Supporting Evidence
- Two NAT1 polymorphisms were identified in colorectal cancer patients.
- NAT1 alleles NAT1*4 and NAT1*15 were present at similar frequencies in cancer and control groups.
- The NAT1*14 allele was found only in the colorectal cancer group.
Takeaway
The study looked at changes in a gene related to cancer and found that these changes are rare and don't seem to increase cancer risk.
Methodology
DNA from colorectal cancer patients and controls was analyzed for NAT1 gene polymorphisms using heteroduplex analysis and DNA sequencing.
Potential Biases
Potential confounding factors related to genetic linkage between NAT1 and NAT2 may affect results.
Limitations
The study's findings may not apply to populations outside of the Scottish Caucasian group studied.
Participant Demographics
Participants included 260 colorectal cancer patients and 323 healthy controls, with a similar gender distribution and age range.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website